Promising research studies surrounding the medication Retatrutide , specifically the high-dose formulation referred to as ZPHC, reveal a considerable impact on body mass decrease and linked metabolic conditions . Experts posit that this combined acting , influencing both GLP-1 and GIP receptors , could offer a major advance in the approach of exce